ARA

Prof. Dr. Alaattin YILDIZ İstanbul Florence Nightingale Hastanesi - İç Hastalıkları (Dahiliye)

Doktordan Randevu Al
Doktordan Randevu Al
Özel İlgi Alanları
  • Böbrek Yetmezliği
  • Diyabetik Nefropati
  • Böbrek
  • Böbrek Nakli
  • Hemodiyaliz

Randevu Alın

İstanbul Florence Nightingale Hastanesi

    • 2003
      İstanbul Üniversitesi
      Profesör

      1992
      İstanbul Üniversitesi
      İç Hastalıkları Uzmanlığı

      1987
      İstanbul Üniversitesi - İstanbul Tıp Fakültesi
      Tıp Eğitimi

      • Türk Nefroloji Derneği
      • Hipertansiyon Diyaliz ve Transplantasyon Derneği
      • Türk Organ Nakli Kuruluşları ve Koordinasyon Derneği
      • International Society of Nephrology
      • European Renal Association-European Dialysis and Transplant Association
  • Uluslararası Hakemli Dergilerde Yayımlanan Makaleler

      • Ekşioğlu-Demiralp E, Alan S, Sili U, Bakan D, Ocak İ, Yürekli R, Alpay N, Görçin S, Yıldız A.      Peripheral innate and adaptive immune cells during COVID-19: Functional neutrophils, pro-inflammatory monocytes, and half-dead lymphocytes. Cytometry B Clin Cytom. 2021 Nov 30. doi: 10.1002/cyto.b.22042.
      • Ozkok A, Alpay N, Alan S, Bakan ND, Soysal F, Yazici H, Ekşioğlu-Demiralp E, Yildiz A. Immunological parameters associated with the severity of COVID-19 pneumonia in kidney transplant recipients. Int Urol Nephrol. 2021 Aug 20:1–12. doi: 10.1007/s11255-021-02947-y.
      • Ozturk S, Turgutalp K, Arici M, ve ark. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study. Int J Clin Pract. 2021 Sep;75(9):e14428. doi: 10.1111/ijcp.14428. Epub 2021 Jun 17.
      • Chertow GM, Pergola PE, Farag YMK, ve ark. PRO2TECT Study Group. Vadadustat in Patients with    Anemia and Non-Dialysis-Dependent CKD. N Engl J Med. 2021 Apr 29;384(17):1589-1600. doi: 10.1056/NEJMoa2035938 
      • Oto OA, Ozturk S, Turgutalp K, ve ark. Predicting the outcome of COVID-19 infection in kidney transplant recipients. BMC Nephrol. 2021 Mar 19;22(1):100. doi: 10.1186/s12882-021-02299-w.
      • Turgutalp K, Ozturk S, Arici M ve ark. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19. BMC Nephrol. 2021 Jan 14;22(1):29. doi:10.1186/s12882-021-02233-0.
      • Ozturk S, Turgutalp K, Arici M, ve ark. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transplant. 2020 Dec 4;35(12):2083-2095. doi: 10.1093/ndt/gfaa271.
      • Turunc V, Ari E, Guven B, Tabendeh B, Yildiz A. Once- vs Twice-Daily Tacrolimus: Survival Rates and Side Effects: Single-Center Experience. Transplant Proc. 2019 Sep;51(7):2308-2311. doi:10.1016/j.transproceed.2019.01.149. Epub 2019 Aug 7.
      • Heerspink HJL, Parving HH, Andress DL ve ark. SONAR Committees and Investigators. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.
      • Erdan A, Ozkok A, Alpay N, Akkaya V, Yildiz A. Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients. Int J Artif Organs. 2018 Jul;41(7):378-384. doi: 10.1177/0391398818778212. Epub 2018 May 28.
      • Ozkok A, Yildiz A. Endothelial Progenitor Cells and Kidney Diseases. Kidney Blood Press Res. 2018;43(3):701-718. doi: 10.1159/000489745. Epub 2018 May 10.     
      • Ozkok A, Atas R, Cinar SA, Yilmaz A, Aktas E, Deniz G, Yildiz A. CD133+  cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients. BMC Nephrol. 2017 Jul 26;18(1):250. doi: 10.1186/s12882-017-0663-x.  
      • Aliyeva N, Demir E, Caliskan Y, Yazici H, Yildiz A. A Rare Clinical Entity: Staphylococcus-Related Glomerulonephritis. Exp Clin Transplant. 2017 Mar 28. doi: 10.6002/ect.2016.0066. 
      • de Fijter JW, Holdaas H, Øyen O, ve ark. ELEVATE Study Group. Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. Am J Transplant. 2017 Jul;17(7):1853-1867. doi: 10.1111/ajt.14186. Epub 2017 Feb 14.   
      • Üstündağ S, Doğan E, Duranay M, Kazancıoğlu R, Çelik V, Ünsal A, Altıntepe L, Dursun B, Akbaş E, Özdener F, Yıldız A. Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Predialysis Patients. Balkan Med J. 2016 May;33(3):322-30. doi: 10.5152/balkanmedj.2016.141173. Epub 2016 May 1. 
      • Duman N, Uyanik A, Unsal A, Sezer S, Camsari T, Cirit M, Yilmaz ME, Altun B, Duranay M, Yildiz A, Sahin I, Dogukan A, Ustundag S, Karayaylali I, Kahveci A, Sindel S, Kiykim AA, Yenicerioglu Y, Akbas E, Ozdener F. Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia. Clin Kidney J. 2014 Oct;7(5):464-9. doi: 10.1093/ckj/sfu079. Epub 2014 Jul 29.  
      • Yilmaz BA, Caliskan Y, Yilmaz A, Ozkok A, Bilge AK, Deniz G, Sariyar M, Yildiz A. Cardiovascular-renal changes after kidney donation: one-year follow-up study. Transplantation. 2015 Apr;99(4):760-4. doi: 10.1097/TP.0000000000000414.   18: Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies. World J Gastroenterol. 2014 Jun 28;20(24):7544-54. doi: 10.3748/wjg.v20.i24.7544.  
      • Akagun T, Caliskan Y, Yazici H, Ozkok A, Telci A, Turkmen A, Yildiz A, Sever MS. Elevated resistin levels are associated with inflammation in hemodialysis patients with failed renal allografts. Int J Artif Organs. 2014 May;37(5):358-63. doi: 10.5301/ijao.5000319. Epub 2014 Apr 4. PMID: 24811303.  
      • Alpay N, Ozkok A, Caliskan Y, Akagun T, Cinar SA, Deniz G, Sariyar M, Yildiz A. Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients. Clin Exp Nephrol. 2014 Dec;18(6):961-7. doi: 10.1007/s10157-014-0939-4. Epub 2014 Feb 11.  
      • Ozkok A, Kekik C, Karahan GE, Sakaci T, Ozel A, Unsal A, Yildiz A. FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. BMC Nephrol. 2013 Nov 1;14:241. doi: 10.1186/1471-2369-14-241.  
      • Guney M, Ozkok A, Caliskan Y, Pusuroglu H, Yazici H, Tepe S, Oflaz H, Yildiz A. QT dispersion predicts mortality and correlates with both coronary artery calcification and atherosclerosis in hemodialysis patients. Int Urol Nephrol. 2014 Mar;46(3):599-605. doi: 10.1007/s11255-013-0549-1. Epub 2013 Sep 14.  
      • Ozkok A, Aktas E, Yilmaz A, Telci A, Oflaz H, Deniz G, Yildiz A. Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients. Clin Nephrol. 2013 Jan;79(1):21-30. doi: 10.5414/CN107318.  
      • Caliskan Y, Yelken B, Ozkok A, Gorgulu N, Yazici H, Telci A, Yildiz A. Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C. BMC Nephrol. 2012 Jul 7;13:56. doi: 10.1186/1471-2369-13-56.   
      • Caliskan Y, Yildiz A. Evaluation of the medically complex living kidney donor. J Transplant. 2012;2012:450471. doi: 10.1155/2012/450471. Epub 2012 May 13.  
      • Ozkok A, Caliskan Y, Sakaci T, Erten G, Karahan G, Ozel A, Unsal A, Yildiz A. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. Clin J Am Soc Nephrol. 2012 Jun;7(6):965-73. doi: 10.2215/CJN.11191111. Epub 2012 Apr 5.  
      • Yelken B, Caliskan Y, Gorgulu N, Altun I, Yilmaz A, Yazici H, Oflaz H, Yildiz A. Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol. 2012 Apr;77(4):275-82. doi: 10.5414/cn107352.  
      • Caliskan Y, Yelken B, Gorgulu N, Ozkok A, Yazici H, Telci A, Turkmen A, Yildiz A, Sever MS. Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants. J Ren Nutr. 2012 Mar;22(2):258-267. doi: 10.1053/j.jrn.2011.07.005. Epub 2011 Nov 3.  
      • Turkmen K, Gorgulu N, Uysal M, Ozkok A, Sakaci T, Unsal A, Yildiz A. Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients. Indian J Nephrol. 2011 Apr;21(2):90-4. doi: 10.4103/0971-4065.82128.   
      • Yazici H, Oflaz H, Pusuroglu H, Tepe S, Dogan C, Basci A, Akkaya V, Yildiz A. Hypervolemia rather than arterial calcification and extracoronary atherosclerosis is the main determinant of pulse pressure in hemodialysis patients. Int Urol Nephrol. 2012 Aug;44(4):1203-10. doi: 10.1007/s11255-011-0024-9. Epub 2011 Jul 5.  
      • Koc M, Dogan C, Arinsoy T, Tonbul Z, Ayli D, Cirit M, Sever MS, Yilmaz ME, Unsal A, Suleymanlar G, Ok E, Basci A, Yildiz A. Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysis patients. Hemodial Int. 2011 Jul;15(3):366-73. doi:10.1111/j.1542-4758.2011.00547.x. Epub 2011 Apr 20.   32: Caliskan Y, Demirturk M, Ozkok A, Yelken B, Sakaci T, Oflaz H, Unsal A, Yildiz A. Coronary artery calcification and coronary flow velocity in haemodialysis patients. Nephrol Dial Transplant. 2010 Aug;25(8):2685-90. doi:10.1093/ndt/gfq113. Epub 2010 Feb 26.  
      • Gorgulu N, Yelken B, Caliskan Y, Elitok A, Cimen AO, Yazici H, Oflaz H, Golcuk E, Ekmekci A, Turkmen A, Yildiz A, Sever MS. Endothelial dysfunction in hemodialysis patients with failed renal transplants. Clin Transplant. 2010 Sep-Oct;24(5):678-84. doi: 10.1111/j.1399-0012.2009.01160.x.  
      • Ozturk S, Soyluk O, Karakaya D, Yazici H, Caliskan YK, Yildiz A, Bozfakioglu S. Is decline in serum albumin an ominous sign for subsequent peritonitis in peritoneal dialysis patients? Adv Perit Dial. 2009;25:172-7.   35: Yelken BM, Gorgulu N, Caliskan Y, Yazici H, Turkmen A, Yildiz A, Sever MS. Comparison of nutritional status in hemodialysis patients with and without failed renal allografts. Clin Transplant. 2010 Jul-Aug;24(4):481-7. doi: 10.1111/j.1399-0012.2009.01097.x. 
      • Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C, Bozfakioglu S, Issever H, Yildiz A. Oral health and inflammation in patients with end-stage renal failure. Perit Dial Int. 2009 Jul-Aug;29(4):472-9.  
      • Caliskan Y, Yazici H, Gorgulu N, Yelken B, Emre T, Turkmen A, Yildiz A, Aysuna N, Bozfakioglu S, Sever MS. Effect of pre-transplant dialysis modality on kidney transplantation outcome. Perit Dial Int. 2009 Feb;29 Suppl 2:S117-22.  
      • Caliskan Y, Oflaz H, Pusuroglu H, Boz H, Yazici H, Tamer S, Karsidag K, Yildiz A. Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clin Nephrol. 2009 Feb;71(2):147-57. doi: 10.5414/cnp71147.  
      • Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C, Besler M, Trablus S, Issever H, Aysuna N, Ozkan O, Yildiz A. Effect of educational level on oral health in peritoneal and hemodialysis patients. Int J Dent. 2009;2009:159767. doi: 10.1155/2009/159767. Epub 2009 Mar 10.   Ozturk S, Kocabay G, Topcular B, Yazici H, Cagatay AA, Bahat G, Baykan B, Turkmen A, Yildiz A. Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with renal failure. Clin Exp Nephrol. 2009 Apr;13(2):138-144. doi: 10.1007/s10157-008-0115-9. Epub 2008 Dec 17. 
      • Caliskan Y, Oflaz H, Demirturk M, Yazici H, Turkmen A, Cimen A, Elitok A, Yildiz A. Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients. Clin Transplant. 2008 Nov-Dec;22(6):785-93. doi:10.1111/j.1399-0012.2008.00879.x.   
      • Ozturk S, Taymez DG, Bahat G, Demirel R, Yazici H, Aysuna N, Sakar S, Yildiz A. The influence of low dialysate sodium and glucose concentration on volüme distributions in body compartments after haemodialysis: a bioimpedance analysis study. Nephrol Dial Transplant. 2008 Nov;23(11):3629-34. doi: 10.1093/ndt/gfn274. Epub 2008 May 28.  
      • Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C, Bozfakioglu S, Besler M, Trablus S, Issever H, Yildiz A. Evaluation of periodontal parameters in patients undergoing peritoneal dialysis or hemodialysis. Oral Dis. 2008 Mar;14(2):185-9. doi: 10.1111/j.1601-0825.2007.01372.x.   
      • Ozturk S, Arpaci D, Yazici H, Taymez DG, Aysuna N, Yildiz A, Sever MS. Outcomes of acute renal failure patients requiring intermittent hemodialysis. Ren Fail. 2007;29(8):991-6. doi: 10.1080/08860220701641819.   
      • Bayraktar G, Kurtulus I, Duraduryan A, Cintan S, Kazancioglu R, Yildiz A, Bural C, Bozfakioglu S, Besler M, Trablus S, Issever H. Dental and periodontal findings in hemodialysis patients. Oral Dis. 2007 Jul;13(4):393-7. doi: 10.1111/j.1601-0825.2006.01297.x.  
      • Tonbul HZ, Demir M, Altintepe L, Güney I, Yeter E, Türk S, Yeksan M, Yildiz A. Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail. 2006;28(4):287-94. doi: 10.1080/08860220600583625.  
      • Can M, Demirtaş S, Polat O, Yildiz A. Is cystatin C a reliable renal marker in trauma? Clin Chem Lab Med. 2006;44(4):510-1. doi: 10.1515/CCLM.2006.071.   
      • Turk S, Atalay H, Altintepe L, Güney I, Okudan N, Tonbul HZ, Gökbel H, Kücür R, Yeksan M, Yildiz A. Treatment with antidepressive drugs improved quality of life in chronic hemodialysis patients. Clin Nephrol. 2006 Feb;65(2):113-8. doi:10.5414/cnp65113.    
      • Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant. 2005 Apr;20(4):760-7. doi: 10.1093/ndt/gfh611. Epub 2005 Feb 16.  
      • Bayraktar G, Kazancioglu R, Bozfakioglu S, Yildiz A, Ark E. Evaluation of salivary parameters and dental status in adult hemodialysis patients. Clin Nephrol. 2004 Nov;62(5):380-3. doi: 10.5414/cnp62380.   
      • Altintepe L, Kurtoglu E, Tonbul Z, Yeksan M, Yildiz A, Türk S. Lower erythropoietin and iron supplementation are required in hemodialysis patients with hepatitis C virus infection. Clin Nephrol. 2004 May;61(5):347-51. doi:10.5414/cnp61347.     
      • Yildiz P, Oflaz H, Cine N, Genchallac H, Erginel-Unaltuna N, Yildiz A, Yilmaz V. Endothelial dysfunction in patients with asthma: the role of polymorphisms of ACE and endothelial NOS genes. J Asthma. 2004 Apr;41(2):159-66.doi: 10.1081/jas-120026073.  
      • Yildiz A, Tepe S, Oflaz H, Yazici H, Pusuroglu H, Besler M, Ark E, Erzengin F. Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients. Nephrol Dial Transplant. 2004 Apr;19(4):885-91. doi: 10.1093/ndt/gfh001.  
      • Oflaz H, Pusuroglu H, Genchallac H, Demirel S, Bugra Z, Sever MS, Yildiz A. Endothelial function is more impaired in hemodialysis patients than renal transplant recipients. Clin Transplant. 2003 Dec;17(6):528-33. doi: 10.1046/j.1399-0012.2003.00100.x.  
      • Türk S, Guney I, Altintepe L, Tonbul Z, Yildiz A, Yeksan M. Quality of life in male hemodialysis patients. Role of erectile dysfunction. Nephron Clin Pract. 2004;96(1):c21-7. doi: 10.1159/000075568.   
      • Alsancak S, Aydin M, Yildiz A,Salman S, Seçkin S. No association between oxidative stress and IL-6 in NIDDM patients with nephropathy. Folia Biol (Praha). 2003;49(6):235-7.
      • Gökkuşu CA, Ozden TA, Gül H, Yildiz A. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. Clin Biochem. 2004 Feb;37(2):94-7. doi: 10.1016/j.clinbiochem.2003.10.009.   
      • Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions. J Biol Chem. 2003 Nov 21;278(47):46616-24. doi: 10.1074/jbc.M307155200. Epub 2003 Sep 15.  
      • Kiyan E, Kilicaslan Z, Gurgan M, Tunaci A, Yildiz A. Clinical and radiographic features of pulmonary tuberculosis in non-AIDS immunocompromised patients. Int J Tuberc Lung Dis. 2003 Aug;7(8):764-70.  
      • Yildiz A, Yazici H, Cine N, Kazancioglu R, Akkaya V, Sever MS, Ark E, Erginel-Unaltuna N. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis. J Nephrol. 2003 May- Jun;16(3):399-403.    
      • Yildiz A, Ikizler A. Radyokontrast nefropati ve onlenmesi [Prevention of radiocontrast nephropathy]. Anadolu Kardiyol Derg. 2003 Jun;3(2):104-6. Turkish.  
      • Tonbul Z, Altintepe L, Sözlü C, Yeksan M, Yildiz A, Türk S. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int. 2003;23(1):46-52.  
      • Yildiz A, Oflaz H, Pusuroglu H, Mercanoglu F, Genchallac H, Akkaya V, Ikizler TA, Sever MS. Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients. Am J Kidney Dis. 2003 Mar;41(3):616-23. doi: 10.1053/ajkd.2003.50123.   
      • Kayacan SM, Yildiz A, Kazancioglu R, Sahin S, Sever MS, Ark E. The changes in serum leptin, body fat mass and insulin resistance after renal transplantation. Clin Transplant. 2003 Feb;17(1):63-8. doi: 10.1034/j.1399-0012.2003.02078.x.   
      • Yildiz A, Hursit M, Celik AV, Kayacan SM, Yazici H, Akkaya V, Gürol AO, Karsidag K. Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study. Clin Nephrol. 2002 Dec;58(6):405-10. doi: 10.5414/cnp58405.    
      • Yildiz P, Tükek T, Akkaya V, Sözen AB, Yildiz A, Korkut F, Yilmaz V. Ventricular arrhythmias in patients with COPD are associated with QT dispersion. Chest. 2002 Dec;122(6):2055-61. doi: 10.1378/chest.122.6.2055.   
      • Yildiz A, Tütüncü Y, Yazici H, Akkaya V, Kayacan SM, Sever MS, Carin M, Karşidağ K. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation. 2002 Oct 27;74(8):1109-13. doi: 10.1097/01.TP.0000031542.08424.85.  
      • Tonbul Z, Altintepe L, Sözlü C, Yeksan M, Yildiz A, Türk S. Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients. J Hum Hypertens. 2002 Aug;16(8):585-9. doi: 10.1038/sj.jhh.1001449.  
      • Cefle K, Yildiz A, Palanduz S, Ozturk S, Ozbey N, Kylyçaslan I, Colakoglu S, Balci C. Chronic renal failure in a patient with Sotos syndrome due to autosomal dominant polycystic kidney disease. Int J Clin Pract. 2002 May;56(4):316-8.  
      • Bayraktar G, Kazancioglu R, Bozfakioglu S, Ecder T, Yildiz A, Ark E. Stimulated salivary flow rate in chronic hemodialysis patients. Nephron. 2002 Jun;91(2):210-4. doi: 10.1159/000058394.  
      • Galliano M, Campagnoli M, Rossi A, Wirsing von König CH, Lyon AW, Cefle K, Yildiz A, Palanduz S, Ozturk S, Minchiotti L. Molecular diagnosis of analbuminemia: a novel mutation identified in two Amerindian and two Turkish families. Clin Chem. 2002 Jun;48(6 Pt 1):844-9.   
      • Yildiz A, Yazici H, Cine N, Akkaya V, Kayacan SM, Sever MS, Erginel-Unaltuna N. The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients. Clin Transplant. 2002 Jun;16(3):173-9. doi: 10.1034/j.1399-0012.2002.01058.x.     
      • Türk S, Yildiz A, Tükek T, Akkaya V, Aras U, Türkmen A, Uras AR, Sever MS. The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.  Int Urol Nephrol. 2001;32(4):713-6. doi: 10.1023/a:1015052312866.   
      • Türk S, Akbulut M, Yildiz A, Gürbilek M, Gönen S, Tombul Z, Yeksan M. Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron. 2002 Feb;90(2):188-94. doi: 10.1159/000049041.  
      • Sever MS, Turkmen A, Sahin S, Yildiz A, Ecder T, Kayacan MS, Nane I, Aydin AE, Eldegez U. Renal transplantation in amyloidosis secondary to familial Mediterranean fever. Transplant Proc. 2001 Nov-Dec;33(7-8):3392-3. doi: 10.1016/s0041-1345(01)02461-7.  
      • Yildiz A, Akkaya V, Tükek T, Sahin S, Sever MS, Bozfakioğlu S, Korkut F. Increased QT dispersion in hemodialysis patients improve after renal transplantation: a prospective-controlled study. Transplantation. 2001 Nov 15;72(9):1523-6. doi: 10.1097/00007890-200111150-00009.  
      • Sever MS, Kazancioğlu R, Yildiz A, Türkmen A, Ecder T, Kayacan SM, Celik V, Sahin S, Aydin AE, Eldegez U, Ark E. Outcome of living unrelated (commercial) renal transplantation. Kidney Int. 2001 Oct;60(4):1477-83. doi: 10.1046/j.1523-1755.2001.00951.x.  
      • Türk S, Karalezli G, Tonbul HZ, Yildiz M, Altintepe L, Yildiz A, Yeksan M. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001 Sep;16(9):1818-22. doi: 10.1093/ndt/16.9.1818.  
      • Kayacan SM, Türkmen A, Aliş H, Imer M, Barlas O, Ecder ST, Yildiz A, Aydin AE, Eldegez U, Sever MS. Successful therapy combined with surgery for severe post-transplant nocardiosis. J Nephrol. 2001 Jul-Aug;14(4):304-6.   
      • Yildiz A, Cine N, Akkaya V, Sahin S, Ismailoğlu V, Türk S, Bozfakioğlu S, Sever MS. Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study. Transplantation. 2001 Aug 15;72(3):542-4. doi:10.1097/00007890-200108150-00035   
      • Yildiz A, Akkaya V, Kiliçaslan I, Türkmen A, Görçin B, Atilgan D, Sever MS. Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever. J Nephrol. 2001 Mar-Apr;14(2):125-7.   
      • Yildiz A, Akkaya V, Sahin S, Tükek T, Besler M, Bozfakioglu S, Korkut F. QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients. Perit Dial Int. 2001 Mar-Apr;21(2):186-92.  
      • Kazancioğlu R, Korular D, Sever MS, Türkmen A, Aysuna N, Kayacan SM, Sahin S, Yildiz A, Bozfakioğlu S, Ark E. The outcome of patients presenting with crush syndrome after the Marmara earthquake. Int J Artif Organs. 2001 Jan;24(1):17-21.  
      • Kazancioğlu R, Sever MS, Yüksel-Onel D, Eraksoy H, Yildiz A, Celik AV, Kayacan SM, Badur S. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin Transplant. 2000 Feb;14(1):61-5. doi: 10.1034/j.1399-0012.2000.140111.x.  
      • Yildiz A, Akkaya V, Hatemi AC, Cine N, Tükek T, Görçin B, Demirel S, Türk S, Sever MS. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients. Nephron. 2000 Feb;84(2):130-5. doi: 10.1159/000045560.    
      • Sayiner A, Ece T, Duman S, Yildiz A, Ozkahya M, Kiliçaslan Z, Tokat Y. Tuberculosis in renal transplant recipients. Transplantation. 1999 Nov 15;68(9):1268-71. doi: 10.1097/00007890-199911150-00009..   
      • Yildiz A, Akkaya V, Yildiz P, Tûrk S, Görel N, Sever MS, Badur S. No relation of tuberculin reactivity with quantitative analysis of peripheral blood lymphocyte subsets in haemodialysis patients. Respir Med. 1999 Feb;93(2):119-22. doi: 10.1016/s0954-6111(99)90301-3.    
      • Yildiz A, Erkoç R, Sever MS, Türkmen A, Ecder ST, Türk S, Kiliçarslan I, Ark E. The prognostic importance of severity and type of post-transplant proteinuria. Clin Transplant. 1999 Jun;13(3):241-4. doi: 10.1034/j.1399-0012.1999.130304.x. PMID: 10383104.    
      • Yildiz A, Beşişik F, Akkaya V, Sever MS, Bozfakioğlu S, Yilmaz G, Ark E. Helicobacter pylori antibodies in hemodialysis patients and renal transplant recipients. Clin Transplant. 1999 Feb;13(1 Pt 1):13-6. doi: 10.1034/j.1399-0012.1999.t01-1-130102.x. PMID: 10081629.   
      • Yildiz A, Sever MS, Türkmen A, Ecder T, Türk S, Akkaya V, Ark E. Interaction between cyclosporine A and verapamil, felodipine, and isradipine. Nephron. 1999 Jan;81(1):117-8. doi: 10.1159/000045262. PMID: 9884436.   
      • Sever MS, Yildiz A, Eraksoy H, Badur S, Yüksel-Onel D, Görçin B, Türk S, Erkoç R. Immune response to Haemophilus influenzae type B vaccination in renal transplant recipients with well-functioning allografts. Nephron. 1999 Jan;81(1):55-9. doi: 10.1159/000045246. PMID: 9884420.   
      • Ecder ST, Sever MS, Yildiz A, Türkmen A, Kayacan SM, Kiliçaslan I, Koçak T, Eldegez U. Kaposi's sarcoma after renal transplantation in Turkey. Clin Transplant. 1998 Oct;12(5):472-5. PMID: 9787959.   
      • Türkmen A, Yildiz A, Erkoç R, Ecder T, Görçin B, Türk S, Aydin AE, Eldegez U, Ark E, Sever MS. Transplantation in renal amyloidosis. Clin Transplant. 1998 Oct;12(5):375-8. PMID: 9787944.    
      • Sever MS, Türkmen A, Yildiz A, Ecder T, Orhan Y. Fever in dialysis patients with recently rejected renal allografts. Int J Artif Organs. 1998 Jul;21(7):403-7. PMID: 9745995.   
      • Yildiz A, Akkaya V, Türk S, Sever MS, Ark E, Yildiz P. Tuberculin responsiveness in hemodialysis patients. Chest. 1998 Sep;114(3):947-8. doi: 10.1378/chest.114.3.947-b. PMID: 9743198.    
      • Yildiz A, Sever MS, Demirel S, Akkaya V, Türk S, Türkmen A, Ecder T, Ark E. Improvement of uremic autonomic dysfunction after renal transplantation: a heart rate variability study. Nephron. 1998 Sep;80(1):57-60. doi: 10.1159/000045126. PMID: 9730704.    
      • Yildiz A, Sever MS, Türkmen A, Ecder T, Beşişik F, Tabak L, Ece T, Kiliçarslan I, Ark E. Tuberculosis after renal transplantation: experience of one Turkish centre. Nephrol Dial Transplant. 1998 Jul;13(7):1872-5. doi: 10.1093/ndt/13.7.1872. PMID: 9681753.    
      • Yildiz A, Akkaya V, Sever MS, Bozfakioglu S, Kudat H, Demirel S, Ark E. Heart rate variability in patients with secondary amyloidosis. Isr J Med Sci. 1997 Dec;33(12):781-5. PMID: 9464346.   
      • Türkmen A, Sever MS, Ecder T, Yildiz A, Aydin AE, Erkoç R, Eraksoy H, Eldegez U, Ark E. Posttransplant malaria. Transplantation. 1996 Nov 27;62(10):1521-3. doi: 10.1097/00007890-199611270-00027.   100: Sever MS, Türkmen A, Yildiz A, Ecder T. Successful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant. 1996